Use of umbilical cord blood cells for the treatment of neurological disorders

The invention relates to medicine and deals with using umbilical cord blood nucleated stem cells for treatment of neurological and mental disorders. This invention concerns using human umbilical cord blood nucleated cells for treatment of neurological and mental disorders bearing no risk of developm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEBEDEV, KONSTANTIN EDUARDOVICH, PAVLOVA, LYUBOV KONSTANTINOVNA, POLYAKOV, YURIY IZRAILEVICH, SMULEVICH, ANATOLIY BOLESLAVOVICH, PALTSEV, MIKHAIL ALEKSANDROVICH, MOROZOVA, YANA VYACHESLAVOVNA, ROMANOV, YURIY ASKOLDOVICH, BOIKO, ALEKSEY NIKOLAEVICH, PROSHKIN, SERGEY DMITRIEVICH, SMIRNOV, VLADIMIR NIKOLAEVICH, KHACHATRIAN, WILLIAM ARANOVICH, DUBNITSKAYA, ETHERI BRONESLAVOVNA, SUKHIKH, GENNADIY TIKHONOVICH, DAVYDOVSKAYA, MARIA VAFAEVNA, SAVCHENKO, VALERIY GRIGORIEVICH, KLIMOV, IGOR ALEKSANDROVICH, GAVRILOVA, SVETLANA IVANOVNA, MEDVEDEV, SVYATOSLAV VSEVODOLOVICH, RADAEV, SERGEY MAKSIMOVICH
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to medicine and deals with using umbilical cord blood nucleated stem cells for treatment of neurological and mental disorders. This invention concerns using human umbilical cord blood nucleated cells for treatment of neurological and mental disorders bearing no risk of development of immunopathological states, not requiring HLA-typing and without limitations in repeated use in case of clinical indications. In accordance with the invention umbilical cord blood nucleated cells are introduced to the patient suffering from neurological or mental disorders in the therapeutically efficient amount which depending on the patient's weight and clinical presentation ranges from 1x10 8 to 5x10 8 and preferably from about 2,2x10 8 to about 2,8x10 8 of cells per infusion.